by Riley Nolan | Jul 21, 2021 | Events, Featured
Hilton Apollolaan Apollolaan 138, 1077 BG Amsterdam, Netherlands The seminar will focus on translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics. This event is scheduled for Friday, October 1,...
by Riley Nolan | Jul 6, 2021 | Events, Featured
The Westin Tokyo 1 Chome-4-1 Mita, Meguro Tokyo, Japan 153-8580 The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates, and network with potential collaborators. This event is scheduled...
by Riley Nolan | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
by Riley Nolan | Mar 11, 2021 | Events, Featured, Webinars
Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...
by Riley Nolan | Feb 17, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...
by Riley Nolan | Jan 26, 2021 | Events, Featured, Webinars
The FDA hosted a virtual workshop January 26, 2021 to provide updates and foster discussions around non-clinical assays for comparative immunogenicity risk assessment of generic peptide products. EpiVax CEO/CSO, Annie De Groot, presented an update on EpiVax’s...
